A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective

<div>Mutation landscape of UBE2S in cancers. UBE2S alteration frequency with specific types (a), general mutation counts (b), and protein mutation sites (c) were depicted across different tumor types.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective 

Figure 3 | A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective 